Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine, octreotide and albumin for cirrhotic patients with functional renal impairment
2011-005825-36Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Feb 2012
- Modality
- Peptides, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of midodrine, octreotide and albumin (human) in Cirrhosis and chronic kidney disease (CKD), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Change in glomerular filtration rate at 12 weeks. Started Feb 2012; status: completed.
02
Drugs
midodrineoctreotidealbumin (human)
03
Conditions
Cirrhosischronic kidney disease (CKD)
Beyond the preview
Go deeper on 2011-005825-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005825-36.